BTRX-335140

NMRA-335140 · Neumora Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BTRX-335140, covering 2025-05-29 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo [Phase 2]